Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study
Abstract
Background Infection with Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae causes substantial mortality and long-term morbidity in children. We know of no study to assess the long-term trends in hospital admission rates for meningitis and septicaemia caused by these pathogens in children in England. We aimed to do such a study using routinely reported data in England.Methods In this population-based observational study, we used datasets that include routinely collected administrative statistics for hospital care: the Hospital In-Patient Enquiry (data for England from 1968 to 1985), the Hospital Episode Statistics dataset (data for England from 1989 onwards), and the Oxford record linkage study (data for Oxfordshire and surrounding areas from 1963 to 2011). We analysed annual age-specific and age-standardised admission rates in children younger than 15 years with H influenzae, meningococcal and pneumococcal meningitis, and septicaemia.Findings We saw a reduction in hospital admission rates for childhood invasive bacterial disease after the introduction of conjugate vaccines against H influenzae, N meningitidis, and S pneumoniae in England. Annual incidence of H influenzae meningitis per 100,000 children decreased from 6·72 admissions (95% CI 6·18-7·26) in 1992 to 0·39 admissions (0·26-0·52) in 1994, after the introduction of routine H influenzae type b vaccination. We saw a small rise in admissions in the early 2000s, peaking at 1·24 admissions per 100,000 children (0·99-1·48) in 2003, which decreased to 0·28 per 100,000 children (0·17-0·39) by 2008 after the introduction of catch-up (2003) and routine (2006) booster programmes for young children. Meningococcal disease increased during the 1990s, reaching a peak in 1999, with 34·54 admissions (33·30-35·78) per 100,000 children. Hospital admissions decreased after the meningococcal serogroup C vaccine was introduced in 1999 and was 12·40 admissions (11·68-13·12) per 100,000 in 2011. Admissions for invasive pneumococcal disease increased from the 1990s reaching a peak in 2006 at 4·45 admissions for meningitis (95% CI 4·0-4·9) per 100,000 children and 2·81 admissions for septicaemia (2·45-3·17) per 100,000 children. A reduction in admissions occurred after the introduction of the pneumococcal conjugate vaccine in 2006: hospital admission rates in 2011 were 2·03 per 100,000 children for meningitis and 1·12 per 100,000 children for septicaemia.Interpretation Vaccine-preventable invasive bacterial disease in children has decreased substantially in England in the past five decades, most notably with the advent of effective conjugate vaccines since the 1990s. Ongoing disease surveillance and continued development and implementation of vaccines against additional pneumococcal serotypes and serogroup B meningococcal disease are important.Funding None.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Vaccines targeted against N. meningitidis serogroups A or C, or a tetravalent A, C, Y, and W135 vaccine have been incorporated into vaccine programs in many countries and have led to a documented decrease in cases due to these serogroups.
“Vaccines targeted against N. meningitidis serogroups A or C, or a tetravalent A, C, Y, and W135 vaccine have been incorporated into vaccine programs in many countries over recent years, and have led to a documented decrease in cases due to these serogroups. [11, 12]”
From Global etiology of bacterial meningitis: A systematic review and meta-analysis. (2018) · cites this paper as [11]
Cites
Systematic review of discharge coding accuracy
Burns, E. M., Rigby, E., Mamidanna, R., Bottle, A., Aylin, P. P., Ziprin, P., & Faiz, O. D. (2011) · Journal of Public Health · doi:10.1093/pubmed/fdr054 · Cited by 699 · see citing works
Miller, E., Andrews, N. J., Waight, P. A., Slack, M., & George, R. C. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70090-1 · Cited by 642 · see citing works
Edmond, K., Clark, A., Korczak, V. S., Sanderson, C., Griffiths, U. K., & Rudan, I. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70048-7 · Cited by 631 · see citing works
Bacterial meningitis in children
Sáez‐Llorens, X., & McCracken, G. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13693-8 · Cited by 535 · see citing works
Peltola, H., Käythy, H., Sivonen, A., & Mäkelä, P. H. (1977) · PEDIATRICS · doi:10.1542/peds.60.5.730 · Cited by 496 · see citing works
Miller, E. J., SALISBURY, D. M., & Ramsay, M. E. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00299-7 · Cited by 483 · see citing works
Andrews, N. J., Waight, P. A., George, R. C., Slack, M., & Miller, E. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.09.019 · Cited by 239 · see citing works
Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine
Miller, E., Andrews, N. J., Waight, P. A., Slack, M., & George, R. C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.112 · Cited by 205 · see citing works
McVernon, J., Andrews, N. J., Slack, M., & Ramsay, M. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13171-6 · Cited by 191 · see citing works
Gill, P. J., Goldacre, M. J., Mant, D., et al. (2013) · Archives of Disease in Childhood · doi:10.1136/archdischild-2012-302383 · Cited by 174 · see citing works
Self-citationA Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program
O’Ryan, M., Stoddard, J. J., Toneatto, D., et al. (2013) · Drugs · doi:10.1007/s40265-013-0155-7 · Cited by 172 · see citing works
Ramsay, M. E., McVernon, J., Andrews, N. J., Heath, P. T., & Slack, M. P. (2003) · The Journal of Infectious Diseases · doi:10.1086/376997 · Cited by 172 · see citing works
Meningococcal C conjugate vaccine: the experience in England and Wales
Campbell, H., Borrow, R., Salisbury, D., & Miller, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.067 · Cited by 168 · see citing works
Tsai, C. J., Griffin, M. R., Nuorti, J. P., & Grijalva, C. G. (2008) · Clinical Infectious Diseases · doi:10.1086/587897 · Cited by 160 · see citing works
Heath, P. T. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.86.6.396 · Cited by 138 · see citing works
Ladhani, S. N., Flood, J. S., Ramsay, M. E., Campbell, H., Gray, S. J., Kaczmarski, E. B., Mallard, R. H., Guiver, M., Newbold, L. S., & Borrow, R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.03.011 · Cited by 124 · see citing works
Ladhani, S. N., Slack, M., Andrews, N. J., et al. (2012) · Emerging infectious diseases · doi:10.3201/eid1901.120741 · Cited by 101 · see citing works
Ladhani, S. N., Slack, M., Heys, M., et al. (2007) · Archives of Disease in Childhood · doi:10.1136/adc.2007.126888 · Cited by 93 · see citing works
Lee, Y. C., Kelly, D. F., Yu, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/524668 · Cited by 76 · see citing works
Trotter, C. L., Waight, P., Andrews, N. J., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.12.008 · Cited by 75 · see citing works
Pichon, B., Ladhani, S. N., Slack, M., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01917-12 · Cited by 72 · see citing works
Schoendorf, K. C., Jl, K., Adams, W. G., & Wenger, J. D. (1994) · PEDIATRICS · doi:10.1542/peds.93.4.663 · Cited by 71 · see citing works
Essentials of clinical immunology
Borek, F. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90020-7 · Cited by 66 · see citing works
Return of Haemophilus influenzae type b infections
Rijkers, G. T., Bondt, P. E. V.-D., Spanjaard, L., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13201-1 · Cited by 58 · see citing works
Added value of PCR-testing for confirmation of invasive meningococcal disease in England
Heinsbroek, E., Ladhani, S. N., Gray, S. J., Guiver, M., Kaczmarski, E., Borrow, R., & Ramsay, M. E. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.06.007 · Cited by 56 · see citing works
Chamberlain, R. (1958) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1958.tb06200.x · Cited by 54 · see citing works
Martin, N. G., & Snape, M. D. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.814862 · Cited by 53 · see citing works
Self-citationPeltola, H., Salo, E., & Saxén, H. (2004) · BMJ · doi:10.1136/bmj.38301.657014.79 · Cited by 46 · see citing works
Completeness of statutory notification for acute bacterial meningitis.
Goldacre, M. J., & Miller, D. L. (1976) · BMJ · doi:10.1136/bmj.2.6034.501 · Cited by 41 · see citing works
Self-citationTrends in Invasive Pneumococcal Disease—Associated Hospitalizations
Shah, S. S., & Ratner, A. J. (2005) · Clinical Infectious Diseases · doi:10.1086/498745 · Cited by 38 · see citing works
Johnson, A. P., Waight, P., Andrews, N. J., et al. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.07.009 · Cited by 31 · see citing works
Geographic correlation between deprivation and risk of meningococcal disease: an ecological study
Williams, C. J., Willocks, L., LAKE, I. R., et al. (2004) · BMC Public Health · doi:10.1186/1471-2458-4-30 · Cited by 29 · see citing works
Capture-recapture analysis and pneumococcal meningitis estimates in England.
Gjini, A., Stuart, J. M., George, R. C., et al. (2004) · PubMed · doi:10.3201/eid1001.030123 · Cited by 25 · see citing works
Ladhani, S. N., Ramsay, M. E., & Slack, M. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31822ef670 · Cited by 24 · see citing works
Meningococcal Disease in Children in Merseyside, England: A 31 Year Descriptive Study
Stanton, M. C., Taylor-Robinson, D. C., Harris, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025957 · Cited by 23 · see citing works
Norheim, G., Sadarangani, M., Omar, O., Yu, L., Mølbak, K., Howitz, M. F., Olcén, P., Haglund, M., ENDE, A. V. D., & Pollard, A. J. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-003312 · Cited by 20 · see citing works
Self-citationLong-Term Sequelae of Childhood Bacterial Meningitis
Hudson, L. D., Viner, R., & Christie, D. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0332-6 · Cited by 17 · see citing works
Goldacre, M. J., Wotton, C. J., & Maisonneuve, J. J. (2013) · Epidemiology and Infection · doi:10.1017/s095026881300099x · Cited by 11 · see citing works
Self-citationDm, J., & Eb, K. (1991) · PubMed · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
ESCMID guideline: diagnosis and treatment of acute bacterial meningitis
van de Beek, D., Cabellos, C., Dzupova, O., Esposito, S., Klein, M., Kloek, A. T., Leib, S. L., Mourvillier, B., Ostergaard, C., Pagliano, P., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.007 · Cited by 919 · see citing works
Global etiology of bacterial meningitis: A systematic review and meta-analysis.
Oordt-Speets, A. M., Bolijn, R., van Hoorn, R. C., Bhavsar, A., & Kyaw, M. H. (2018) · PloS One · doi:10.1371/journal.pone.0198772 · Cited by 288 · see citing works
Acute bacterial meningitis in adults
McGill, F., Heyderman, R. S., Panagiotou, S., Tunkel, A. R., & Solomon, T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30654-7 · Cited by 274 · see citing works
Castelblanco, R. L., Lee, M., & Hasbun, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70805-9 · Cited by 245 · see citing works
Martin, N. G., Iro, M. A., Sadarangani, M., Goldacre, R., Pollard, A. J., & Goldacre, M. J. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30201-8 · Cited by 78 · see citing works
Self-citationLoop-mediated isothermal amplification methods for diagnosis of bacterial meningitis
Seki, M., Kilgore, P. E., Kim, E. J., Ohnishi, M., Hayakawa, S., & Kim, D. W. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00057 · Cited by 60 · see citing works
Villalpando-Carrión, S., Henao-Martínez, A. F., & Franco-Paredes, C. (2024) · Current Tropical Medicine Reports · doi:10.1007/s40475-024-00316-0 · Cited by 15 · see citing works
- Authors
- Martin, N. G., Sadarangani, M., Pollard, A. J., & Goldacre, M. J.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Martin, Natalie G
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 14
- Issue
- 5
- Pages
- 397-405
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W2007545021
- Cited by
- 131
- References
- 39
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 8 · 2023: 4 · 2022: 6 · 2021: 12 · 2020: 4 · 2019: 13 · 2018: 14 · 2017: 14 · 2016: 12 · 2015: 21 · 2014: 11
- FWCI
- 15.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- English National Institute for Health Research (grant number RNC/035/002)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Neonatal and Maternal Infections
- Keywords
- septicemia, hospitalization rates, conjugate vaccines, Haemophilus influenzae type b vaccine, meningococcal conjugate vaccine, pneumococcal conjugate vaccine, vaccine impact, temporal trends
- MeSH terms
- Adolescent, Child, Child, Preschool, England, Female, Haemophilus influenzae, Hospitalization, Humans, Infant, Male, Meningitis, Haemophilus, Meningitis, Meningococcal, Meningitis, Pneumococcal, Neisseria meningitidis, Streptococcus pneumoniae, Incidence, Bacteremia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review